(Q36681528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

review article

1 reference

title

Therapeutic advances for glioblastoma multiforme: current status and future prospects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

H Ian Robins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Susan Chang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Nicholas Butowski

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

66-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02951428

23 December 2019

exact match

0 references

cites work

Platelet-derived growth factor receptors: a therapeutic target in solid tumors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02951428

A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy

21 January 2018

1 reference

12 December 2020

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

12 December 2020

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.

1 reference

12 December 2020

Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.

1 reference

12 December 2020

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

12 December 2020

The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.

1 reference

12 December 2020

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

1 reference

12 December 2020

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

12 December 2020

Chemopotentiation by PARP inhibitors in cancer therapy.

1 reference

12 December 2020

Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Factorial designs for randomized clinical trials.

1 reference

12 December 2020

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

1 reference

12 December 2020

Methodology for small clinical trials

1 reference

12 December 2020

Changing paradigms--an update on the multidisciplinary management of malignant glioma

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

12 December 2020

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

1 reference

12 December 2020

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

12 December 2020

Factorial design considerations.

1 reference

12 December 2020

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

12 December 2020

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

1 reference

12 December 2020

Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach.

1 reference

12 December 2020

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series

1 reference

12 December 2020

Current management of glioblastoma multiforme

1 reference

12 December 2020

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02951428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17164050%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference